NEWS

In Spain, most of the investment in health research and development is made by the public sector, mainly in research centers dependent on the Administration and universities, but once transferred to the pharmaceutical […]

Germán Velásquez is one of the most well know individuals in the debate on access to medicines due to his criticism on government immobility and the loss of independence and credibility of […]

Transparency is one of It’s not Healthy’s goals. Since its launch three years ago, the campaign has been claiming that citizens should know how much is being paid for publicly-financed drugs that have an […]

Esteemed Minister:     First of all, we would like to congratulate you on your appointment as Minister of Health, Consumer Affairs and Social Welfare. It is a source of great pride […]

We spoke with Ancel-la Santos, the Policy Advisor of Health Action International, an NGO working on the European level to improve the affordability and rational use of drugs. Ancel-la coordinates political advocacy […]

This week we signed a collaboration agreement with the Health Service of the Balearic Islands to implement public policies on transparency and impartiality in the rendering of health activities. This is the first […]

Cancer treatments are among the highest-priced and generate the most profit for the pharmaceutical industry. However, there is significant public investment in the research phases and the clinical trials of many these […]

Dear Mrs. Minister:   These days the press has been speaking of the launch of a new funding model for drugs with high economic impact for rare diseases as well as oncology. […]

The Ministry of Health has announced this week the launch of a new model of financing medicines of high economic and health impact aimed at new therapies for rare diseases and cancer. […]

This week, through communication mediums, we became aware that the government obligates the autonomous communities to solicit financial support from the Autonomous Liquidation Fund (ALF) and sign an agreement that guarantees minimum annual […]

Surgery, chemotherapy and radiotherapy have always formed the therapeutic arsenal to combat different types of cancer. However, in the last decade, a new type of treatment that begins to position itself as […]

30 non-governmental and civil society organizations from 17 European countries have submitted a new opposition this week to the patent of Sofosvbir, the drug that cures Hepatitis C. The resource is based […]